NEW YORK, March 29 (GenomeWeb News) - Xennex has licensed its GeneCards database to the European Patent Office, the Cambridge, Mass.-based company said today.
Patent examiners at the EPO will use GeneCards to review and approve patent applications in the life sciences area. They plan to use the database to conduct prior art research, to determine whether an invention can be patented, and to retrieve information to support other patent-related activities. The product will be available to EPO employees at sites in Munich, Berlin, the Hague, and Vienna. In addition, national patent offices of EPO's member states will have access to the software. Xennex did not disclose financial details of the agreement.
GeneCards, developed by bioinformaticists at the Weizmann Institute of Science in Israel, is a compendium of human genes and their encoded proteins and provides information on functional genomics and medical aspects, including involvement in disease.